Resilient and Innovative Health Systems for Europe · Patient-centred care Resilient Gx policy B1 W9 W10 EU Health programme Men's health W6 W7 EC Transatlantic lessons State of the

Building Resilient Healthcare Systems

Free-Trade Zone EU-US. Implications for Health Systems

Investing in Health

Mental Health. The Motor for a Healthy Economy

mHealth for Innovation. Health at your Fingertips

Non-Communicable Diseases

Resilient and InnovativeHealth Systems for Europe

Supported by the European Commission

European Health Forum

GASTEIN

In addition to the official programme, the eventprovides a vast array of opportunities for informalmeetings, discussion and networking.

9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:00 19:00 20:00 21:00

Wed

nesd

ayTh

ursd

ayFr

iday

Satu

rday

Closing Plenary

Opening Plenary

Welcome reception

Networking evening

EC receptionConclusion evening

S O C I A L P R O G R A M M E

W1

W2

W3

Tackling NCD in Russia & CIS

Patient-centred care

Resilient Gx policy

B1

W9

W10

EU Health programme

Men's health

W6

W7

EC

Transatlantic lessons

State of the art in cancer

Anti-discrimination in health

W4

W5

Knowledge translation

Health economics

L1

L2

HAI

Self-care perceptions

L3

L4

Schizophrenia and inclusion

Navigating health systems

W11 Big Data

W8 A health literate Europe

Healthcare optimisation (starts 7.30am)

B2 Patient involvement (starts 7.30am)

F1

F2

F3

Investing in health

Free-Trade Zone EU-US

Mental health

F1

F2

F3

Investing in health


Mental health

F4

F5

F6

mHealth


Building resilient healthcare systems

F4

F5

F6

mHealth



edne

sday

10:009:00

W

ackling NCD in Russia & CIS

y

tient-centred care

Resilient Gx policW3

aPW2

TW1

12:0011:00 13:00

y Opening Plenarackling NCD in Russia & CIS

tient-centred care

16:0015:0014:00

y

Mental health

rade Zone EU-US

Investing in health

F1

ree-TFF3

F2

18:0017:00 19:00

wledge transla

Health economicsW5

KnoW4

rade Zone EU-US

Investing in health

a

elc

20:0019:00 21:00

c come receptionW

tiondge transla

Health economics

a

althcare optimisa

Thur

sday

B1 Hea tion (starts 7.30am)a

Mental health

rade Zone EU-US

Investing in health

F1

ree-TFF3

F2


mHealth

F4

F5

am)

EU Health programme

A health litera

W9

HAI

Self-care perceptionsL2

L1

Schizophrenia and inc

ting health systems ts 7.30a

W8

vigaNaL4

L3

rade Zone EU-US


mme

o

U Health program

te Europe urope

perceptio ons

s

enia and

health s

A health litera

systems

d lusion inc



mHealth

F4

F6

F5 tlantic lessons

tion in health

te of the art in cancer

Anti-discriminaEC

StaW7

ransaTW6



n in healthNetworking evening

so

on in health

n

th

cancer

ons

ent involvement

riday

turd

ay

ti (starts 7.

SaF

aPB2

Non-Communicable DiseasesF6

onEC receptio

A M M E A L P R O G R S O C I

tient involvement (starts 7.30am)

Men's health

Big Da

W10

W11


yClosing Plenar

A M M E

Men's health

taBig Da lusion evening Conc

European Health Forum Gastein

The EHFG is the leading health policy conference in Europe. The main objective isto facilitate the establishment of a framework for advising and developing Europeanhealth policy while recognising the principle of subsidiarity.

Target groupThose participating in the event include senior policy and decision-makersrepresenting politics and government at EU, national and regional levels; businessand industry; health care funders and service providers; civil society; as well asexperts and researchers in health care and public health.

Bad HofgasteinThe Gastein valley lies at the heart of the ‘HoheTauern’ nature reserve, the largest of its kind inCentral Europe. World famous for its thermalsprings it is a year round tourist resort offering alarge range of high-quality accommodation. Mostcongress hotels are within walking distance of thecongress venue which is located in the centre ofthis typical Austrian village.

Programme Overview

F – parallel forum session W – workshop L – lunch workshop B – breakfast workshop

Recent developments in Europeshow that we have selected a late-breaking topic for this year’sEuropean Health Forum Gastein.Some European countries are ontheir way to economic consolidationand we have witnessed theintroduction of new governancemodels in banking and finance.These developments will have director indirect consequences on healthand health systems.

I am convinced that in the course ofthis year’s conference we willidentify the necessary ingredientsfor a health system to be bothresilient and open for innovativeapproaches, in order to come out ofthe crisis strengthened and to beable to address the manifold futureresponsibilities.

For the plenaries we could winimportant speakers who will share ahelicopter-perspective with theaudience and update us on recentdevelopments. We look forward toworking interactively with you in thefora and workshops and to involvingyou in discussions on particulartopics and cases related to ourmain theme of Resilient andInnovative Health Systems forEurope.

See you in Gastein in October!

Helmut BrandPresident International Forum Gastein

Conference language The conference language is English.

Plenary sessions

12:30–14:30 • Wednesday • 2 October 2013

15:00–17:00 • Friday • 4 October 2013

Opening plenary session

Welcome address and official opening H Brand, President, International Forum GasteinZ Jakab, Regional Director, WHO Regional Office for EuropeP Testori Coggi, Director-General, DG Health and Consumers, European Commission

Keynote speech: How to use innovation on the way to recoveryUE Reinhardt, James Madison Professor of Political Economy, Professor of Economics andPublic Affairs, Woodrow Wilson School of Public and International Affairs, Princeton University,USA

EU-Trio Presidency debate

Closing plenary session

A Stöger, Minister of Health, Austria

T Borg, EU Commissioner for Health

Video reflectionT Rose, Independent EU Health Advocate, Brussels, Belgium

Conclusion

Members of the European Parliament debate

Accessibility Most of our facilities are easily accessible to guests with disabilities. For further enquiries or to advise us of youraccess needs, please contact our team on +43 6432 3393 270 or email to [email protected].

The future development of health and health systems will be at the core of this year’s EHFG.We would like to build on last year’s topic of Health in an Age of Austerity by taking thediscussion further and asking: “What can we learn from the current financial and political crisisand how can we react in a resilient and innovative way for better population health and moreeffective health systems?” Recent struggles with the impact of the crisis have shown us theurgent need to rethink current policies and approaches.

In the plenary sessions we will address the following questions:• What will future resilient health systems look like?• On which innovative health system approaches should we concentrate?• Are policy-makers stepping up to the challenges of the future?

mailto:[email protected]

Mental health will be the motor for ahealthy economy in the 21st century.In order to successfully face currentand future economic, social andpublic health challenges, all relevantpolicies and mental healthcareservices must be reshaped based onsmart, innovative, cost-efficient andintegrated delivery models.

In this forum we will aim to analysethe value of targeted policymeasures and the differentcomponents integrated policyapproaches should encompass.Participants will be invited to analysethe integration of mental healthpromotion and the management ofbrain diseases into broader healthand employment policies in order toeffectively tackle current and futuresocial and economic challenges.

In the session’s debates we willconsider the following questions:

• The broader health, social andeconomic impact of mental health

• The value of prioritising mentalhealth and key developmentoutcomes in health, employmentand research policies as well ashealthcare planning

• Innovative policy measures thatcould be undertaken at global, EUand national levels in order tosupport integrated policyapproaches to mental health,holistic disease management andprevention models across health,employment and research policies

• Case studies of depression andalcohol dependence and theirimpact on the workplace andproductivity

Organised by Lundbeck A/S

Mental health. The motor for a healthy economy

Session 2 9:00–12:00 • Thursday • 3 October 2013

Session 1 15:00–18:00 • Wednesday • 2 October 2013

Innovative mental health delivery models in times of austerity and financial crisis

Introduction: Representative of DG CONNECT, European Commission

The discussion will focus on the following questions:• What are the real values of health prevention strategies in the area of mental health? • What approaches and policy trends are occurring at global and regional levels? • What is the role of the European Union in the improvement of mental health and holistic,targeted policies?

• Which key components should integrated mental health policies encompass? • What innovative experiences in health management could be successfully applied tomental health management and service planning?

• What are the crucial patient needs that will set up tomorrow's mental health landscape?

Round-table discussion with:D McDaid, Scientific expert, Editor of Eurohealth Representative of the World Health Organization Representative of the OECD Representative of DG Health and Consumers, European Commission Representative of the EU Lithuanian Presidency Representative of a patient organisation Moderated by P O’Donnell, Journalist

Mental health: Europe's greatest health challenge in the 21st century?

Introduction: A Werthmann, Member of the European Parliament (tbc)

The discussion will focus on the following questions:• What are the social and economic impacts of brain diseases in Europe and globally?• What impact do brain diseases have on work productivity and the broader community: thecase studies of depression and alcohol dependence.

• What are the main research and policy gaps in this area which should be addressed toovercome health, social and economic challenges of the 21st century?

• What concrete components should targeted workplace policies encompass to promotemental health, prevent brain disorders and to help people stay and reintegrate at work?

• What is the role of the EU in supporting national efforts in this direction?

Round-table discussion with:Representative of DG Employment, Social Affairs & Inclusion, European CommissionRepresentative of the World Economic Forum (tbc)P Anderson, Professor, Maastricht University, The NetherlandsD Shenker, Alcohol Health Network, UKRepresentative of the World Federation for Mental Health (WFMH) (tbc)

Moderatored by P Kelly, Journalist

As a result of the financial andeconomic crisis, several MemberStates of the European Unionreduced their budgets which led to adrop in health expenditure for thefirst time in decades.

Beyond the possible direct orindirect effects on the health of thepopulation, budgetary constraintsforce countries to rethink how toreform their health systems to makethem fit for purpose to addressgrowing challenges such as anageing population, patients’expectations and technologicalprogress with at times decreasedresources.

In these parallel forum sessions thespeakers will:

• Highlight the need for effectiveinvestments in health systems andthe health status of the population

• Exemplify areas of investing inhealth that could lead to gains inefficiency of public spending, tobetter quality of care and toreducing inequalities in health

• Discuss different approaches tothe reform of national healthsystems in the EU, includingthrough prevention and healthpromotion

• Highlight examples of policyinnovation in health systems

• Showcase good practice fromMember Countries of theEuropean Union

Organised by DG Health andConsumers of the EuropeanCommission

Investing in health. From health to wealth



Investing in health – the case for better public spending

Introduction and moderation of interactive discussionJ Figueras, Director, European Observatory on Health Systems and Policies

Investing in healthP Testori Coggi, Director General, Health and Consumers, European Commission

Where to invest, where to cut? Healthcare reforms in times of austerityR Arafat, Secretary of State for Health, Ministry for Health, Romania (tbc)M Szócska, Minister of State for Health, Ministry of National Resources, Hungary

Resolving the efficiency and quality dilemma

Introduction and moderation of interactive discussionN Klazinga, Senior Health Policy Analyst, OECD (tbc)

Health systems performance assessment – in search for the magic formulaO Wigzell, Deputy Director General, Ministry of Health and Social Affairs, Sweden

Health Technology Assessment – opportunities and limitations R Tarricone, Project Director, HTA Project at CERGAS, Bocconi University, Italy

Resolving the efficiency and quality dilemma – the Portuguese experienceP Pita Barros, Professor of Economics, Centre for Economic Policy Research, UK

Patients’ perspective N Bedlington, Executive Director, European Patients’ Forum

Prevention – a way to avoid the financing and ageing dilemma?

Introduction and moderation of interactive discussionC Needle, Director, EuroHealthNet

The economics of prevention F Sassi, Senior Health Economist, OECD (tbc)

Children’s health – investing in a healthy future J Mackenbach, Chair of the Department of Public Health, Erasmus MC, The Netherlands (tbc)

Innovation in active and health ageing – the case of frailty preventionP Guillet, Chief Geriatrician, Sanofi

From health to wealth – priorities for investment by 2020

Round-table discussion:A Parvanova, Member of the European Parilament (ALDE, Bulgaria) (tbc)C Vitcheva, Director, DG Regional Policy and Urban (DG REGIO), European Commission (tbc)PH Smit, Advisor, AgathellonM Kosinska, Secretary General, European Public Health AllianceC Needle, Director, EuroHealthNet

Moderated by S Giraud, Head of Unit, Strategy and International, DG Health and Consumers,European Commission

The world's biggest free-trade zonenegotiations between the EU andthe US are a historic opportunity toaddress legacy issues such as theindependence of the nationalregulatory authorities.

The EU Commissioner for Trade,Karel De Gucht, has called it a“living agreement” to be finished bythe end of 2014. The Treaty of Rome(1957) was groundbreaking inpromoting the idea of an “evercloser union”. Is that compatiblewith the Trans-Atlantic Free TradeAgreement (TAFTA)? Politics canshift the sands quickly, creating a“tragedy of the commons” scenarioin which an overall positive outcomeis blocked by special interests.

On the other hand, there is greathope that cooperation will reduceunnessary regulation on both sidesof the Atlantic. However, healthcareis not an arena where the freemarket works perfectly. For example,can the FDA and other Americanauthorities accept Europeancertificates without question andvice versa?

The parallel forum will discuss thepro-and-con implications for healthfocussing on products, services,providers and users. Above all, theopportunities for innovationcollaboration will be analysed.

The forum will address:

• Medical devices and drugs -regulatory issues and bottlenecks

• Implications for personalisedmedicine and healthcare

• Importance of positioning

• Adding value for citizens andhealth systems

Organised by European Alliance forPersonalised Medicine (EAPM), IPHGat Maastricht University and MaxPlanck Institute for MolecularGenetics (MPIMG)




Implications for health systems

IntroductionA Brand, Institute for Public Health Genomics, Maastricht University, The Netherlands

Expectations EUB Merkel, Minister Counselor, Delegation to the United States of America, European Union

Expectations US H Wong, Deputy Assistant Secretary for Global Affairs, US Department of Health and HumanServices, USA (tbc)

National level perspectiveS Smits, Vice Minister for Foreign Economic Relations, Netherlands Ministry of Foreign Affairs,The Netherlands (tbc)

Open Society Foundations (OSF) perspectiveE Torreele, Director, Access to Essential Medicines Initiative, Open Society Foundations, USA

Interactive Panel Discussion

Chaired by E Anklam, Director, Institute for Reference Materials and Measurements, JointResearch Centre, European CommissionCo-chaired by S Berghmans, VP Academic & Research Relations EU, Elsevier Global AcademicRelations, The Netherlands

Implications for health systems

Industry perspectiveRepresentative from industry

Patient organisation perspectiveG McVie, Secretary, European Alliance for Personalised Medicine (EAPM)

Food and Drug Administration (FDA) perspectiveL Valdez, Associate Commissioner for International Programs, Food and Drug Administration,USA (tbc)

European Medicines Agency (EMA) perspectiveF Ehmann, Scientific Support and Projects, European Medicines Agency (EMA), UK

European Parliament perspectiveV Moreira (S&D, Portugal), Chair of the TRADE Committee, Europan Parliament

Interactive Panel Discussion

Chaired by E Anklam, Director, Institute for Reference Materials and Measurements, JointResearch Centre, European CommissionCo-chaired by S Berghmans, VP Academic & Research Relations EU, Elsevier Global AcademicRelations, The Netherlands

Resilience is the intrinsic ability of asystem to adapt and respond tounexpected internal and externalpressures and shocks. Like bamboo,it does not crack but swings back,seizing the opportunity forstrengthening and carrying outneeded reform.

In many countries, the financial crisisand the austerity responsecombined with the increasing costsof healthcare have been exercising amajor pressure on health systems.Resilient health systems have beenable to cope better, moving out ofthe crisis stronger than they werebefore and better prepared torespond to the challenges ahead.

In this parallel forum, we will exploresuccessful policy strategies forbuilding health system resiliencedrawing on recent and pastexperience from countries in theregion and elsewhere.

These strategies will be structured inthree major groupings:

• Increasing health system efficiencythrough structural reform andinnovation

• Strengthening the public healthresponse and improving health

• Health system governance

Speakers and panelists will presentexamples of successful reformsimplemented in times of crisis andtogether with the audience we willflesh out good practice lessons forbuilding resilient health systems.

Facilitators and chairs include:B Azaïs, Director Public Policy, MSDJ Figueras, Director, EuropeanObservatory on Health Systems andPoliciesH Kluge, WHO Regional Office forEurope

Organised by MSD together with WHORegional Office for Europe and the EuropeanObservatory on Health Systems and Policies


Session 2 9:00–12:00 • Friday • 4 October 2013


Strengthening health systems resilience: an introduction

In this session, we will clarify key concepts and highlight main policy options for buildingresilient health systems in times of crisis. We will provide a framework and outline mainapproaches including fiscal preparedness; funding mechanisms; structural delivery reforms;health care innovation and acting on social determinants.

This session will draw on the evidence and recommendations stemming from the WHO OsloConference.

Achieving efficiencies in times of crisis

In this session we will discuss how to achieve efficiencies in times of crisis. This includessuccessful structural reform agendas and greater focus on prevention. The emphasis will beput on situations in which reform was possible.

We will explore the specific resources and strategies that have made challenging structuralreforms possible and how scientific research might provide for better prevention tools.

Strengthening public health responses: Health in All Policies and the economics ofprevention

In this session, we will discuss the public health responses during the financial crisis.

The focus of the debate will be again on the specific context and the mechanisms that led toa successful response. We will review the economic case for health promotion andexperiences with implementing Health in All Policies.

Concrete examples will come from national policy-making, the use of sin-taxes, vaccinationand tobacco and alocohol control.

Health and health systems governance: the way to do it

Much can go wrong when it comes to health systems governance in particular during afinancial crisis: Accountability relationships that do not align, lack of transparency thatconceal cost and poor quality, lack of participation when endorsement by implementers andusers is needed, insufficient policy capacity when making complex choices and lack ofintegrity when predictability and trust are precious goods.

Our panelists will share and discuss with the audience their own experience.

In this forum we will look at therecent developments and challengesin the area of mobile health(mHealth).

Use of mobile technology for healthand healthcare/social care hastremendous potential for patientengagement and improved clinicalcare.

However, there is a lack ofawareness of added value andbenefits of mHealth.

Furthermore, guidance with respectto the application of regulation in thearea of mHealth is needed, in orderto protect privacy and security,standards and interoperability.

In the course of this parallel forumwe will explore mHealthopportunities and challenges frommultiple perspectives.

Organised by DG CONNECT of theEuropean Commission

mHealth. Health at your fingertips



Users' viewpoint

Understanding the user perspective M Stampe, KMD, Denmark (tbc)

Use of mobile health apps in psychiatric practiceS Kooij, Psycho-medical Programmes Expertise Centre Adult ADHD, The Netherlands

Example of successful deploymentSpeaker to be announced

World-wide experienceRepresentative of the World Health Organization

People’s view on medical and wellbeing appsA Wyke, Patientview, UK

Interactive discussionModerated by J Thestrup, In-Jet, Denmark

Regulatory issues

Industry viewRepresentative from ‘big companies’ (tbc)Representative of SME representing developers (tbc)

Socioeconomic impact of mHealth – an assessment report for the European UnionRepresentative of PricewaterhouseCoopers

Evaluation of appsSpeaker to be announced

Green Paper on mobile health and wellbeing appsRepresentative of the DG CONNECT, European Commission

Interactive discussionModerated by R Madelin, Director-General, DG CONNECT, European Commission

The World Health Assembly has seta goal of reducing prematuremortality from NCDs by 25% by2025. Evidence-based research,innovative approaches and politicalwill are critical to make a differencein building responsive and robusthealth systems, effect widespreadpolicy shifts and drive behaviouralchange.

We will look at the key policies ofthose countries doing best inpreventing NCD related mortality;hear from policymakers pushingboundaries to build resilient publichealth policy capable of fightingchronic disease, and discuss thepioneering research that will informthe NCD prevention policies of thefuture.

In the first session we will presentrecent research including acomparative analysis of theperformance of public health policiesof particular relevance to NCDs inEurope and Asia, and use interactivemethods to ask the audience toassess factors critical to theirsuccess, what we can learn from thedata presented and how to bringabout change in our differentcountries.

In session two we will consider howpolicy-makers and civil society areresponding to the NCD challenge atnational, regional and global levels.

Organised by Bureau of HealthPromotion, Taiwan, R.O.C.

Non-Communicable Diseases. From research to action


NCD research: critical factors for building resilience

IntroductionM McKee, Professor of Public Health, London School of Hygiene and Tropical Medicine, UK andEuropean Observatory on Health Systems and Policies

NCD health policies in Europe – factors critical for successJ Mackenbach, Chair of the Department of Public Health, Erasmus MC, The Netherlands

Public health policy performance against NCDs: Examples of opportunities and challengesfrom AsiaWT Chiu, Minister of Health, Taiwan, R.O.C

Obamacare and US health policy on NCDsM Cheng, Health Policy Research Analyst, Princeton University, USA

Building health resilience to NCDs: factors that promote or diminish people’s resilience toeconomic shocks, findings from a systematic review and wider implicationsB Roberts, Senior Lecturer in Health Systems and Policy, London School of Hygiene and TropicalMedicine, UK

Interactive plenary discussion and conclusionModerated by M McKee, Professor of Public Health, London School of Hygiene and TropicalMedicine, UK and European Observatory on Health Systems and Policies


Policy developments and innovations in the fight against NCDs

Innovative measures to tackle NCDs in Asia: a policy-maker perspectiveST Chiou, Director-General, Bureau of Health Promotion, Taiwan, R.O.C

Innovative measures to tackle NCDs in Europe: European policy-maker perspectiveMEP (tbc)

The EU contribution to addressing chronic diseasesRepresentative from DG Health and Consumers, European Commission (tbc)

Tobacco control in Taiwan: a Taiwanese NGO perspectiveSW Yau, CEO, John Tung Foundation, Taiwan, R.O.C

Driving prevention from the grassrootsStakeholder representative (tbc)

Key outcomes from the 66th World Health Assembly (Geneva, May 2013) and the WHO European Ministerial Conference on Nutrition and NCDs (Vienna, July 2013)P Rendi-Wagner, Chief Medical Officer, Ministry of Health, Austria

Interactive plenary discussion and conclusionModerated by M McKee, Professor of Public Health, London School of Hygiene and TropicalMedicine, UK and European Observatory on Health Systems and Policies

Tackling NCD in Russia & CISHarnessing innovations to improveaccess and quality of NCD treatmentin Russia and CISHow to tackle Non-CommunicableDisease (NCD) is a growing topic ofimportance in emerging markets andmiddle income countries. The RussianFederation could be perceived as abenchmark country in this group withregard to how NCD issues are beingaddressed.

During the course of the workshop aclear action plan of work on NCD shouldbe developed.

D Borisov, ERL, Russian Federation

Representative of Federal Ministry ofHealth, Russian Federation

I Sedakov, Chief Oncologist, Ukraine

E Nasonov, Institute of Rheumatology,Russian Federation

R Khabriev, Institute of Public Healthcare,Russian Federation

Representative of the Ministry of Health,Kazakhstan

V Yanin, Minister of Public Health,Krasnoyarsk Region, Russian Federation

Other participants will include:Representatives of the Federal andRegional Healthcare Authorities fromRussian Federation and CIS countries

WHO representatives

Healthcare administrators

Representatives of Patients' AdvocacyGroups and NGO leaders

Co-chaired by O Chestnov, AssistantDirector-General, NCD and Mental Health,WHO


Organised by Non-commercial PartnershipEqual Right to Life

Patient-centred careExploring barriers and solutions topatient-centred care in diabetesChronic diseases pose an ever growingburden on societies across Europe at atime of economic crisis. There isgrowing recognition of the need toimplement innovative healthcaresolutions to better prevent, detect andcontrol chronic diseases. At the heart ofthis are the people and families livingtheir daily lives with chronic conditions.Empowering these people and deliveringpatient-centred care will be essential tomaintain sustainable healthcaresystems. But what are the barriers andsolutions to address this challenge?

By using diabetes as a case study, thisworkshop will:

• Explore the social and psychologicalbarriers to implementing patient-centred care.

• Map the current landscape of patient-centred diabetes care in Europe.

• Facilitate dialogue on how to improvepatient involvement, self-managementand psychosocial support as part ofinnovative healthcare.

• Share best practice in the area ofpatient-centred care taking diabetesas a model.

The workshop takes point of departurein the Diabetes Attitudes Wishes andNeeds 2 (DAWN2™) study, which is amultinational study that gives a holisticview on diabetes care with insights frommore than 15,000 people and 17countries.


Sponsored and organised by Novo Nordisk

Resilient Gx policyDespite the promise of generics (Gx) inlowering costs there are concernsaround outcomes and total healthcarecosts which are currently not addressedin generics policies. This workshop willexamine the concerns with genericspolicies and the need for more rationaloff-patent policies in order to strengthenhealthcare systems and widen thediscussion beyond the current paradigmof from lowest-price-priority to value-based priority (cost per health outcome).

The speakers will build on an overviewof healthcare policies regulating on-patent and off-patent pharmaceuticals inrelation to healthcare efficiency and theunderlying definitions before presentingevidence around the impact of suchpolicies on health outcomes, access todrugs and economic parameters as wellas considering funding scenarios.

Alternative models for value baseddecision making and core drivers ofvalue will be discussed and elaboratedwith the audience by using a structuredgroup discussion approach.

N Maniadakis, Professor, National Schoolof Public Health, Greece

Z Kalo, Professor, Eötvös LorándUniversity (ELTE), Hungary

J Shen, Abbott Products Operations AG,Switzerland

H Chung, Head of Health PolicyResearch, Swiss Re Services ltd., UK

Moderated by D Brixner, Professor, PharmacotherapyOutcomes Research, University of Utah,USAAP Holtorf, Health Outcomes StrategiesGmbH, Switzerland


Sponsored by Abbott Products Operations AG,Switzerland and co-organised by HealthOutcomes Strategies GmbH

Workshops

Health economicsStress test for health economicsMost European health systems facemore or less similar conditions: healthexpenditures are rising for differentreasons whereas available funding -depending on the general status ofnational economies - remains on thesame level or is even decreasing.

Only a few countries plan to increasehealth expenditures in a moderate wayin the years to come.

Measures have to be taken to maintainhealth systems resilient and innovativeover a longer period.

Health economists are asked to offersupport and provide their advice. Butare their findings transferable intotangible health policy measures? Aredecisions in health politics based onscientific evidence and good data or aredecisions conditioned by other factors?

The goal of this workshop is to work outwhether health economics is able toprepare or facilitate political processesand decision-making or if healtheconomics has its strength only inretrospective analysis.

PC Smith, Imperial College London, UK

RB Saltman, Health Policy andManagement, Rollins School of PublicHealth, Emory University, USA

CM Auer, Federal Ministry of Health,Austria

Chaired by T Czypionka, Institute forAdvanced Studies, Austria


Organised by Federal Ministry of Health,Austria

Knowledge translationResearch knowledge translation forpolicy development: barriers andfacilitatorsEvidence-based policy-making requiresevidence emanating from research to beaccessible and presented in such a waythat it fits the needs of policy-makers.

Based on concrete experiences thissession will explore the barriers andfacilitators in knowledge translation.


Organised by DG Research and Innovation ofthe European Commission

Workshops

Healthcare optimisationMoving towards safer and moreefficient health services – evidencefrom the ECHO project on systematicvariations in healthcare deliveryQuality, access and efficiency ofhealthcare services are growingconcerns in Europe and are at the heartof all debates in health policy-makingand management. The EuropeanCollaboration for Health Optimization(ECHO) project is an international effortto deliver unique insights in the variationin utilisation, safety, efficiency of healthsystems and services using both ageographical and hospital approach.

This workshop brings you the first resultsof the project and shows how the outputcan result in better decision-making inhealthcare. Participants will be engagedin discussions around the best possibleuptake of results and how differentstakeholders can engage in turningevidence into good decision making.

The session is co-financed by theEuropean Commission in the frameworkof the 7th Framework Programme (GrantAgreement FP7-health-2009-242189).

7:30–9:00 • Thursday • 3 October 2013

Organised by European Collaboration forHealth Optimization (ECHO) project

Self-care perceptionsEpposi Self-Care Perception Index:Today’s perception can lead to tomorrow’s realitySelf-Care describes the activitiesundertaken by individuals and the widercommunity in order to improve health,prevent disease and manage illness. Thetake-up of Self-Care coincides with agrowing interest in personal health andwellbeing, increased access to healthinformation, and government fundedpublic health promotions that havetargeted smoking, obesity andconsumption of alcohol. All this meansthat there needs to be fundamentalchange to entrench a powerfulpreventative health culture in thecommunity, including the role of Self-Care for those who are able to takegreater responsibility for personal health.

The workshop will explore the results ofa major piece of quantitative researchestablishing a European baseline ofpublic perceptions towards Self-Caregathered in ten EU countries. Thesession will cover issues such as: Howdo consumers define self-care? Who dothey trust in its delivery? What are theopportunities and risks involved andhow can these be managed from apolicy to practice perspective?

Multi-stakeholder discussion leaders ofan open fishbowl conversation:

A representative from the EMA (tbc)

P de Raeve, European Federation ofNurses Associations (EFN)

I Passarani European ConsumerOrganization (BEUC)

V Clay, Pfizer

Moderated by J Bowman-Busato, Epposi


Organised by European Platform for PatientOrganisations, Science and Industry (Epposi)

Schizophrenia and inclusionSchizophrenia and social inclusion:Perspectives, needs and solutionsOnly 8% of people living withschizophrenia in the UK are inemployment. Is this the tip of an iceberghighlighting the true extent of socialexclusion? How are individuals with thissevere brain disorder, diagnosed in theprime of their lives, impacted across keyaspects of their lives, throughout theirlives? What is the unrecognisedpotential for their active role in society?Hot on the heels of the World Federationfor Mental Health 2013 World Congress,which dedicated its programme to socialinclusion, this workshop seeks toaddress the many unansweredquestions for people affected byschizophrenia, both for individuals livingwith the condition and their carers:

• What is the level of social exclusionamong those affected?

• How is social exclusion impactingpeople affected by schizophrenia?

• What are the benefits of integratingpeople affected by schizophrenia – forindividuals and for society?

• What are the policy solutions tosupport integration of those affected?

This highly interactive session will reportfindings of a new global study on socialinclusion. A live survey where yourpersonal votes and opinions will sparkdebate on this key topic will help toinform the relevant policy changesneeded to enhance levels of socialinclusion for those affected.

Speakers and panellists to be announced

Moderated by N Fahy, Senior AdvisorHealth, Edelman


Organised by F. Hoffmann-La Roche Ltd

Workshops

HAIHealthcare-associated infections (HAI)Healthcare-associated infectionsrepresent an urgent public health issueand a threat to the safety of Europeanpatients. Controlling and preventingthese infections is therefore aresponsibility for any healthcare systemand any institution providing healthcareto European patients.

To describe this situation and toillustrate progress that has been made inthe area, this workshop will feature theparticipation of a number of experts whowill discuss the issue from theirperspectives as a government official atthe EU-level, a hospital manager, apatient and a healthcare inspector. Inaddition ECDC will inform the discussionwith the latest data available from acrossthe EU countries.

JF Ryan, DG Health and Consumers,European Commission

E Presterl, Professor, Clinical Institute ofHospital Hygiene, Medical University ofVienna, Austria

J Wijngaarden, Chief Inspector of PublicHealth, The Health Care Inspectorate,Ministry of Health, Welfare and Sport, The Netherlands

L Souchet, European Patients’ Forum

D Monnet, Senior Expert & Head ofProgramme, Antimicrobial Resistance andHealthcare-Associated Infections,European Centre for Disease Preventionand Control

Moderated by M Sprenger, Director,European Centre for Disease Preventionand Control (ECDC)


Organised by European Centre for DiseasePrevention and Control (ECDC)

Navigating health systemsIn April 2013 the Government of Norwayhosted a WHO High-Level Meeting inOslo on “Health systems in times ofglobal economic crisis: an update of thesituation in the WHO European Region”.

The objective of this session is to reviewthe latest evidence on the impact of theeconomic crisis on population healthand on health systems in the WHOEuropean Region, particularly in thefollowing broad areas:

• Maintaining and reinforcing equity,solidarity and universal coverage

• Policy responses to growing fiscalpressure, with a focus on hard-hitcountries and measures to improveefficiency

• Improving health system preparednessand resilience

During the workshop we will present thepolicy lessons and recommendationsfrom the High Level Meeting. These willhave been discussed at the WHORegional Committee in Izmir, Turkey,September 2013 by the 53 WHOEuropean Member States.

Panel discussion with WHO EuropeanMember States and multilateralorganisations on:

• Crisis as an opportunity for healthsystem reforms and revitalizing publichealth (short-term returns and long-term vision)

• Interplay between fiscal policy andhealth financing policy in times ofeconomic downturn: Ireland, Greece,Moldova, ECFIN, OECD

Moderated by H Kluge, WHO Europe


Organised by the World Health Organization,Regional Office for Europe

State of the art in cancerState of the art in cancer: 50 years ofchange – dormancy and development• How can we continue to advance carefor people with cancer in Europe in thecurrent financial climate?

• What public policy changes areneeded in order to keep the cancercare promises of the last 50 years?

This interactive workshop aims toaddress these questions head-on in afast paced speed-networking session,based on the findings of The State ofOncology Report. The report looks at 50years of change in cancer careworldwide – praising successes andcritically examining failures, with a focuson public policy implications for Europeand what lessons should be learned aswe strive to ensure another 50 years ofprogress. The session will be introducedby lead author, Professor Peter Boyle,followed by speed-networking, whereparticipants will get to know eachother’s thoughts and ideas by spendingtime debating the core issues in pairs.The session will then gather together thepoints raised by the audience, invitingthem to share their views and askquestions about the report. Theconclusions drawn by participantsduring the workshop will lay thefoundations for the next steps of TheState of Oncology Report, and the futurework based around it.

P Boyle, International Prevention ResearchInstitute Lyon, France

Facilitated by (speed networking): Y Venable, Head of International PublicPolicy, Roche K Wilhelmsson, Director, Health Policy andMarket Access, Edelman


Organised by F. Hoffmann-La Roche Ltd

Transatlantic lessonsWhat can the US and Europe learnfrom each other?The US and Europe are considered todiffer fundamentally in terms of howhealthcare is organised. Traditionally,Europe focuses on the significant gapsin coverage in the US with large parts ofthe population uninsured orunderinsured. On the other hand, in theUS the European model is often picturedas rigid and overregulated. Thesestereotypes may cloud our views andimpede the potential to learn from eachother’s experience.

With the new Patient Protection andAffordable Care Act that was adopted in2010, it may seem that the US healthsystem is converging towards theEuropean model. However, similarly,reforms in Europe over the last twodecades have been inspired byconcepts and ideas that crossed theAtlantic, such as managed care andcompetition.

In the face of a global economic crisiswith soaring public budgets, it is time totake a closer look at each other’s healthsystem policies and identify bestpractices that could help to overcomethe immense health challenges ahead.

T Rice, Professor, Department of HealthServices, UCLA School of Public Health,USA

UE Reinhardt, James Madison Professorof Political Economy, Professor ofEconomics and Public Affairs, WoodrowWilson School of Public and InternationalAffairs, Princeton University, USA

Panel discussion


Organised by the European Observatory onHealth Systems and Policies

Workshops

Patient involvementThe current economic crisis has resultedin health budget cuts throughout the EU,negatively impacting access toscreening, diagnosis, treatment,rehabilitation and health management –and, ultimately, health outcomes.

A recent Commission Staff WorkingDocument addressing ‘Investment inhealth’ underlines the fundamentalimportance of good health for economicgrowth and personal wellbeing.Achieving high standards of healthshould be considered as one of the keydrivers of economic recovery. Continuedand well-targeted investment in healthand health services is therefore crucial.

Health stakeholders have a place in thisdebate, with patients playing a centralrole as they experience the full budgetrestrictions and diminished access.Increasingly, they are expected to takeon greater responsibility for their healthand lifestyle choices as a condition forsuch access. Given these trends, patientempowerment and health literacy arekey concepts. This session will explore:

• To what extent patients are engagingin the health policy decisions thataffect them and how this engagementcan be fostered to address the gapsacross Europe.

• Which measures can support betterhealth outcomes and how they can beimplemented most effectively.

Representative of DG SANCO, EC (tbc)A Olauson, European Patients' ForumR Muller, GAMIAN-EuropeK Fjellstedt, CPMEM Olsson, EHMAK Kadenbach MEP, S&D Austria (tbc)

Chaired by T Rose, Health Activist

7:30–9:00 • Friday • 4 October 2013

Organised by the European Patients' Forum in cooperation with Sanofi

A health literate EuropeInvesting in health literacy is animportant strategy to foster access tohealth and to put citizens and patients atthe centre of health and healthcare.

The aim of creating a health literateEurope is therefore two-fold: Enhancingthe capacity of European systems tomeet the health needs of the citizens aswell as strengthening citizens’ role withregard to their health, to improve healthoutcomes and to reduce the growingburden on health systems.

The aim of the workshop is to discussthe role of health literacy in creatingresilience towards the challenges of themegatrends such as demographicchange, increase in chronic disease anddecrease in productivity and shaping ahealth literate Europe.

13:00–14:30 • Friday • 4 October 2013

Organised by Maastricht University, EuropeanPatients' Forum, Standing Committee ofEuropean Doctors (CPME) and MSD

Workshops

Anti-discriminationAnti-discrimination in healthEU Session on improving access andcombating discrimination in healthcarewith a focus on vulnerable groups.

This session will explore the two aspectsof discrimination in healthcare andimproving access to healthcare.

In this context the main objectives are:

• To identify issues in relation todiscrimination in the access tohealthcare in the EU.

• To highlight the EuropeanCommission's commitment to thepromotion and protection offundamental rights in access tohealthcare.

• To discuss EU and Member States’possible actions on improving theaccess to healthcare in the EU,identifying gaps and challenges andhighlighting evidence and bestpractices.

The session will present a range ofperspectives of what the current issuesare as well as panel discussions onactions.


Organised by DG Health and Consumersof the European Commission

EU Health programmeEU health programme 2014–2020information workshopThe purpose of the workshop is toinform participants about the new EUHealth programme, its main goals,objectives and funding instruments, aswell as the steps now taken towardsimplementation from 2014.

13:00–14:30 • Friday • 4 October 2013

Organised by DG Health and Consumers of theEuropean Commission

Men's healthImproving men’s use of primary careservices in EuropeMen’s health across Europe isunnecessarily poor, with nearly 630,000men aged 15–64 dying annually acrossthe old EU 27 Member States comparedto 300,000 women. This is a majorhuman and financial cost to men, theirfamilies, communities, employers andnational health systems.

Primary healthcare services are centralto strategies to improve men's health interms of prevention, early diagnosis andtreatment. Currently, however, services(general practice, dentists, pharmacy,optometry and others) are usedineffectively by men. They attend lessfrequently than women, especially forprevention and screening, and it hasbeen suggested that men’s lowercontact with primary care is linked totheir higher use of hospital services.

This workshop will explore why and howmen under-use the range of primary careservices and, more importantly, howmen's access can be improved bychanges to policy and service delivery.

Moderated by I Banks, President,European Men's Health Forum (EMHF)

13:00–14:30 • Friday • 4 October 2013

Organised by European Men's Health Forum(EMHF)

Big DataHow can we harness Big Data toimprove R&D and translation of newtherapies?The ongoing IT revolution has madepossible the ability to analyse enormousdata sets from different locations.Volume, variety, velocity and value arethe key characteristics of datasetsfeeding contemporary algorithms andimproved data mining methodologiescreate new frontiers of statisticalinference. Analytics continue to evolve,with their ability to consume andinterpret terabits of data growingexponentially in power year on year.

Healthcare is an area where Big Datacan have a tremendous impact, markinga transformation from human judgmentto automated decisions for genomics,the development of new therapies, themonitoring of real world efficiency, andimproving the timely delivery of care forpatients.

This workshop will feature a panel ofinternational experts from research,policy and industry discussing new waysto harness Big Data and translate it fromthe lab with better indications, improveour understanding of benefit risk,provide tools for more accurate healthtechnology assessment, and reduce thedreaded efficacy/efficiency gap.

13:00–14:30 • Friday • 4 October 2013

Organised by European Alliance forPersonalised Medicine (EAPM) and sponsoredby EFPIA

Workshops

Booking InformationWe provide a variety of services from which you can choose to make your conference stay as comfortable as possible. • Booking your accommodation• Booking your shuttle service• Participation in social programme eventsParticipation in the lunches is included in the conference fee.

For detailed information please visit our homepage www.ehfg.orgInformation about our social programme is available at www.ehfg.org/social.htmlONLINE REGISTRATION will open during the 2nd week of July 2013. To register please go to www.ehfg.org/registration.htmlAll information in this announcement is subject to change.

CONFERENCE FEESincludes 10% VAT

Early bookinguntil 9 August 2013

Standard fees EUR 1550

Government fees for employees of ministries,local governments, European Parliament EUR 600

Reduced fees available only to representativesof NGOs and full-time staff of universities EUR 500

Cancellation fee is 10% of the total amount due until 6 September2013, 50% until 27 September 2013, 100% thereafter. Cancellationmust be submitted in writing.

Organiser: International Forum Gastein

Coorganisers: Federal Ministry of Health, Austria

With the support of and European Commission, DG Health and Consumersin collaboration with: European Commission, DG CONNECT Land Salzburg European Observatory on Health Systems and Policies

Supporting Organisations

Contact us: T: +43 (6432) 3393270; F: +43 (6432) 3393271; E: [email protected] Forum Gastein, Tauernplatz 1, 5630 Bad Hofgastein, Austria

JOIN US

Facebook

LinkedIn

Twitter

http://www.ehfg.org

http://www.ehfg.org/social.html

http://www.ehfg.org/registration.html

mailto:[email protected]

http://www.facebook.com/gasteinforum/

http://www.linkedin.com/groups/European-Health-Forum-Gastein-3976448?gid=3976448&trk=hb_side_g

https://twitter.com/GasteinForum

Documents

Resilient and Innovative Health Systems for Europe · Patient-centred care Resilient Gx policy B1 W9 W10 EU Health programme Men's health W6 W7 EC Transatlantic lessons State of the